Market research
4549.TSE Eiken Chemical Co., Ltd
TSE JPY Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 80B
- P/E ratio
- 21.98
- Analyst target
- 2100
- Dividend yield
- 2.5%
- Beta
- 0.32
Profile
Company facts
- Exchange
- TSE
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- JP3160700005
- Market cap
- 80B
- P/E ratio
- 21.98
- Analyst target
- 2100
- Dividend yield
- 2.5%
- Beta
- 0.32
About
About Eiken Chemical Co., Ltd
Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate specific antigens; and clinical chemistry tests reagents to measure and analyze biological components in blood serum and urine. In addition, it sells reagents and devices of microbiological test for food poisoning bacteria and environmental inspection; and offers molecular test (LAMP) using nucleic acid amplification method, as well as provides various types of automated analyzers. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was incorporated in 1939 and is headquartered in Tokyo, Japan.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 4549.TSE discussion.
5 years, 6 months ago
Eiken Chemical Co., Ltd is currently in a long term downtrend where the price is trading 0.7% below its 200 day moving average.
From a valuation standpoint, the stock is 96.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.
Eiken Chemical Co., Ltd's total revenue rose by 18.8% to $11B since the same quarter in the previous year.
Its net income has increased by 115.2% to $2B since the same quarter in the previous year.
Based on the above factors, Eiken Chemical Co., Ltd gets an overall score of 3/5.